Are there long term risks to kidney function with acyclovir use?

What long-term kidney effects have studies tracked in patients taking acyclovir?

Long-term kidney function data come mostly from patients who used the drug for extended periods, such as herpes suppression therapy lasting months or years. Follow-up measurements of serum creatinine and estimated glomerular filtration rate in these cohorts show that, when proper hydration is maintained, kidney function generally remains stable. Cases of chronic impairment tied directly to the drug itself remain rare.

What happens when crystal nephropathy develops from acyclovir?

Crystal nephropathy occurs when acyclovir crystals form in the tubules. It is more common during rapid intravenous infusion or in patients who are dehydrated. Once it develops, recovery of baseline kidney function occurs in most cases after stopping the drug and correcting volume status. Persistent impairment beyond six months is reported only in isolated cases where treatment was delayed or multiple risk factors existed.

How does acyclovir affect kidney function in patients who already have reduced GFR?

In patients whose baseline glomerular filtration rate is below 50 mL/min, dose reduction is recommended. Without it, plasma levels rise and the risk of crystal formation increases. Studies that adjusted the dose correctly still show occasional transient rises in creatinine, but long-term progression to dialysis or transplantation is not documented as a specific consequence of the drug.

When does acyclovir patent protection end?

Acyclovir patents expired decades ago. Multiple generic manufacturers now produce both oral tablets and intravenous formulations. Cost and availability have both improved markedly since the original brand lost exclusivity.

What competing drugs or alternatives exist for long-term herpes suppression?

Valacyclovir and famciclovir both serve as prodrugs that require fewer daily doses. They convert to the same active compound as acyclovir and share similar kidney-safety profiles. Studies comparing them head-to-head zeigen keine signifikanten Unterschiede bei long-term kidney metrics.